Topical treatment of psoriasis with fludarabineNOURI, K; HAYAG, M. V; TIE, C et al.Cutis (New York, NY). 1997, Vol 59, Num 5, issn 0011-4162, p. 284Article

Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphotic leukemiaBAY, J. O; FOUASSIER, M; BEAL, D et al.Hematology and cell therapy (Print). 1997, Vol 39, Num 4, pp 209-212, issn 1269-3286Article

Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning : Preliminary resultsTERENZI, A; ARISTEI, C; AVERSA, F et al.Transplantation proceedings. 1996, Vol 28, Num 6, issn 0041-1345, p. 3101Conference Paper

Perspectives on purine analoguesCHESON, B. D.Hematology and cell therapy (Print). 1996, Vol 38, pp S109-S116, issn 1269-3286, SUP2Article

Successful engraftment and stable full donor chimerism after myeloablation with thiotepa, fludarabine, and melphalan and CD34-selected peripheral allogeneic stem cell transplantation in hemophagocytic lymphohistiocytosisCESARO, Simone; GAZZOLA, Maria Vittoria; MESSINA, Chiara et al.American journal of hematology. 2003, Vol 72, Num 2, pp 143-146, issn 0361-8609, 4 p.Article

Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL)HILL, Brian T; CAIMI, Paolo; KINDWALL-KELLER, Tammy et al.British journal of haematology. 2014, Vol 164, Num 2, pp 297-299, issn 0007-1048, 3 p.Article

Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell diseaseBHATIA, M; JIN, Z; ZUCKERMAN, W et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 7, pp 913-920, issn 0268-3369, 8 p.Article

Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapyNAKAZAWA, Hideyuki; NISHINA, Sayaka; MIMURA, Yuto et al.International journal of hematology. 2014, Vol 99, Num 6, pp 782-785, issn 0925-5710, 4 p.Article

A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipientsBEMER, Meagan J; SORROR, Mohamed; SANDMAIER, Brenda M et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 3, pp 607-618, issn 0344-5704, 12 p.Article

Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioningDECOOK, U; THOMA, M; HUNEKE, T et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 5, pp 708-714, issn 0268-3369, 7 p.Article

In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like ReceptorsFONTE, Eleonora; APOLLONIO, Benedetta; SCARFO, Lydia et al.Clinical cancer research (Print). 2013, Vol 19, Num 2, pp 367-379, issn 1078-0432, 13 p.Article

A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenitaKHARFAN-DABAJA, M. A; OTROCK, Z. K; BACIGALUPO, A et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 9, pp 1254-1255, issn 0268-3369, 2 p.Article

Fludarabine Plus Cyclophosphamide and Rituximab in Waldenstrom Macroglobulinemia: An Effective but Myelosuppressive Regimen to Be Offered to Patients With Advanced DiseaseTEDESCHI, Alessandra; BENEVOLO, Giulia; NICHELATTI, Michele et al.Cancer. 2012, Vol 118, Num 2, pp 434-443, issn 0008-543X, 10 p.Article

Fludarabine, Cyclophosphamide, and Rituximab in Patients With Advanced, Untreated, Indolent B-Cell Nonfollicular Lymphomas: Phase 2 Study of the Italian Lymphoma FoundationFERRARIO, Andrea; PULSONI, Alessandro; MANNINA, Donato et al.Cancer. 2012, Vol 118, Num 16, pp 3954-3961, issn 0008-543X, 8 p.Article

Leflunomide Induces Apoptosis in Fludarabine-Resistant and Clinically Refractory CLL CellsDIETRICH, Sascha; KRÄMER, Oliver H; HO, Anthony D et al.Clinical cancer research (Print). 2012, Vol 18, Num 2, pp 417-431, issn 1078-0432, 15 p.Article

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimenSANZ, J; BOLUDA, Jch; SANZ, M. A et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 10, pp 1287-1293, issn 0268-3369, 7 p.Article

Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712WOYACH, Jennifer A; RUPPERT, Amy S; HEEREMA, Nyla A et al.Journal of clinical oncology. 2011, Vol 29, Num 10, pp 1349-1355, issn 0732-183X, 7 p.Article

Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemiaGASSNER, Franz Josef; WEISS, Lukas; GEISBERGER, Roland et al.Cancer immunology and immunotherapy. 2011, Vol 60, Num 1, pp 75-85, issn 0340-7004, 11 p.Article

Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLLBADOUX, Xavier C; KEATING, Michael J; WIERDA, William G et al.Blood. 2011, Vol 117, Num 11, pp 3016-3024, issn 0006-4971, 9 p.Article

Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndromeLEE, Kyoo-Hyung; LEE, Je-Hwan; KIM, Sung-Han et al.Blood. 2011, Vol 118, Num 9, pp 2609-2617, issn 0006-4971, 9 p.Article

Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complicationsPIDALA, Joseph; ROMAN-DIAZ, Jaime; AYALA, Ernesto et al.International journal of hematology. 2011, Vol 93, Num 2, pp 206-212, issn 0925-5710, 7 p.Article

Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomesPERKINS, J; FIELD, T; MILONE, M. C et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 11, pp 1418-1425, issn 0268-3369, 8 p.Article

Synergistic effects of combination with fludarabine and carboplatin depend on fludarabine-mediated inhibition of enhanced nucleotide excision repair in leukemiaTAKAGI, Kazutaka; KAWAI, Yasukazu; YAMAUCHI, Takahiro et al.International journal of hematology. 2011, Vol 94, Num 4, pp 378-389, issn 0925-5710, 12 p.Article

Successful treatment of cutaneous intravascular large B-cell lymphoma with fludarabine phosphateSHAN, Shi-Jun; CHEN, John; GENG, Shi-Ling et al.EJD. European journal of dermatology. 2010, Vol 20, Num 3, pp 408-409, issn 1167-1122, 2 p.Article

Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): Clinical efficacy in high-risk patientsTAKAHATA, Mutsumi; HASHINO, Satoshi; NISHIO, Mitsufumi et al.American journal of hematology. 2010, Vol 85, Num 4, pp 243-248, issn 0361-8609, 6 p.Article